Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0JJ8A
|
||||
Former ID |
DIB016286
|
||||
Drug Name |
CaV2.2 blocker
|
||||
Synonyms |
CaV2.2 blocker (pain); CaV2.2 blocker (pain), Merck & Co
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Investigative | [552036] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
CC(C)(S(=O)(=O)c1cc(cc(C(F)(F)F)c1)F)C1CCN(C(=O)c2ncc(C<br />(F)(F)F)cc2S(=O)(=O)C)CC1
|
||||
Target and Pathway | |||||
Target(s) | Voltage-dependent N-type calcium channel | Target Info | Blocker | [543870] | |
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Ionotropic glutamate receptor pathway | |||||
Metabotropic glutamate receptor group III pathway | |||||
Metabotropic glutamate receptor group II pathway | |||||
Thyrotropin-releasing hormone receptor signaling pathway | |||||
Endogenous cannabinoid signaling | |||||
GABA-B receptor II signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.